Drug Profile
AZD 8418
Alternative Names: AZD8418Latest Information Update: 12 Aug 2010
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Glutamate modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 29 Jul 2010 Discontinued - Phase-I for Schizophrenia in Uganda (PO)
- 28 Jan 2010 Phase-I clinical trials in Schizophrenia in Uganda (PO)